These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1340442)

  • 1. Pharmacokinetics of high-dose methylprednisolone in children.
    Ito S; Kusunoki Y; Oka T; Ito Y; Okuno A; Yoshioka H
    Dev Pharmacol Ther; 1992; 19(2-3):99-105. PubMed ID: 1340442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses.
    Möllmann H; Rohdewald P; Barth J; Möllmann C; Verho M; Derendorf H
    Pharm Res; 1988 Aug; 5(8):509-13. PubMed ID: 3072558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone pharmacokinetics after intravenous and oral administration.
    Al-Habet SM; Rogers HJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):285-90. PubMed ID: 2655680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury.
    Barth J; Winkler J; Schumann R; Nagaraja NV; Madabushi R; Balbach S; Derendorf H; Möllmann H; Möllenhoff G
    Int J Clin Pharmacol Ther; 2004 Sep; 42(9):504-11. PubMed ID: 15487809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of methylprednisolone during acute renal allograft rejection.
    Tornatore KM; Walshe JJ; Reed K; Venuto RC
    Clin Transplant; 1995 Apr; 9(2):74-8. PubMed ID: 7599405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and dose linearity testing of methylprednisolone phosphate.
    Möllmann H; Rohdewald P; Barth J; Verho M; Derendorf H
    Biopharm Drug Dispos; 1989; 10(5):453-64. PubMed ID: 2804250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.
    Ludwig EA; Kong AN; Camara DS; Jusko WJ
    J Clin Pharmacol; 1993 Sep; 33(9):805-10. PubMed ID: 8227476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of methylprednisolone in elderly and young healthy males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Am Geriatr Soc; 1994 Oct; 42(10):1118-22. PubMed ID: 7930339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatography analysis, preliminary pharmacokinetics, metabolism and renal excretion of methylprednisolone with its C6 and C20 hydroxy metabolites in multiple sclerosis patients receiving high-dose pulse therapy.
    Vree TB; Lagerwerf AJ; Verwey-van Wissen CP; Jongen PJ
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):337-48. PubMed ID: 10517356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy.
    Bartoszek M; Brenner AM; Szefler SJ
    Clin Pharmacol Ther; 1987 Oct; 42(4):424-32. PubMed ID: 3665340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated assessment of methylprednisolone pharmacokinetics during chronic immunosuppression in renal transplant recipients.
    Tornatore KM; Reed KA; Venuto RC
    Ann Pharmacother; 1995 Feb; 29(2):120-4. PubMed ID: 7756707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and nonlinear disposition of methylprednisolone and methylprednisone in the rat.
    Haughey DB; Jusko WJ
    J Pharm Sci; 1992 Feb; 81(2):117-21. PubMed ID: 1545348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative methylprednisolone pharmacokinetics in renal transplant patients receiving double- or triple-drug immunosuppression.
    Tornatore KM; Walshe JJ; Reed KA; Holdsworth MT; Venuto RC
    Ann Pharmacother; 1993 May; 27(5):545-9. PubMed ID: 8347899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.
    Fisher LE; Ludwig EA; Wald JA; Sloan RR; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1992 Jun; 51(6):677-88. PubMed ID: 1535301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
    Kearns CM; Blakley RL; Santana VM; Crom WR
    Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass.
    Kong AN; Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Pharmacotherapy; 1990; 10(1):29-34. PubMed ID: 2179900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma.
    Parker TJ; Daley-Yates PT; Wood SA
    Br J Clin Pharmacol; 1997 Jun; 43(6):589-92. PubMed ID: 9205818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid methylprednisolone clearance in a patient with cystic fibrosis.
    Green CG; Kraus CK; Lemanske RF; Farrell PM; Jusko WJ
    Drug Intell Clin Pharm; 1988 Nov; 22(11):876-8. PubMed ID: 3234253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration.
    Rohatagi S; Barth J; Möllmann H; Hochhaus G; Soldner A; Möllmann C; Derendorf H
    J Clin Pharmacol; 1997 Oct; 37(10):916-25. PubMed ID: 9505983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study.
    Kanhai KMS; Zuiker RGJA; Stavrakaki I; Gladdines W; Gaillard PJ; Klaassen ES; Groeneveld GJ
    Br J Clin Pharmacol; 2018 May; 84(5):1020-1028. PubMed ID: 29385232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.